The ratios of proinflammatory to anti-inflammatory cytokines (TNF-α : IL-10, TNF-α : TGF-β, IFN-γ : IL-10, IFN-γ : TGF-β, IL-12 : IL-10, and IL-12 : TGF-β) were significantly lower in plasma samples of B16F10+PBS1d-treated mice compared to B16F10+PBS14d-treated animals (p < 0.001; Figure 1(d)), suggesting that MSCs, administered 1 day after the injection of tumor cells, were exposed to the higher concentration of immunosuppressive cytokines, while MSCs transplanted 14 days after tumor induction were exposed to the higher concentration of inflammatory cytokines. The gene discussed is IL10; the disease is neoplasm.